Summary

Original source:
http://go.reuters.com/newsArticle.jhtml?type=healthNews&storyID=10126619&src=rss/healthNews

Details

• Inc. knew its painkiller Vioxx increased the risk of heart attacks and failed to inform doctors and the public in order to protect profits, an attorney for a man who blames the withdrawn drug for his 2001 heart attack told jurors on Tuesday.
• In his closing argument, Christopher Seeger, lead attorney for the plaintiff in the second Vioxx case to go to trial, accused Merck of concealing evidence that the drug was associated with a rate of heart attacks five times higher than for from another common pain reliever, naproxen.
• The jury began deliberating on Tuesday afternoon after receiving instructions from the judge.
• Merck had said it believed naproxen had heart protective qualities which accounted for the difference in heart attacks seen with Vioxx in a study conducted years before the one that led Merck to pull the Vioxx from the market last year.
• Seeger, in closing arguments lasting almost two and a half hours, rejected claims by the company that Vioxx did not cause the rupture of plaque in a coronary artery of his client, 60-year-old postal worker Frederick Humeston, that triggered the heart attack.
• Using an animated slide of a coronary artery to illustrate his point, he argued that the drug inhibits the formation of prostacyclin -- a substance that prevents the formation of blood clots -- which in turn lead to heart attacks.
• Vioxx had annual revenue of $2.5 billion before it was pulled from the market after a study last year showed long-term use doubled the risk of heart attacks and strokes.
• "Merck calculated cardiovascular warnings would cost the company 50 percent of its profits through 2006," Seeger said, referring to labeling on the drug the company declined to provide.

Related Articles

Popular Topics: Merck, Heart attack, Vioxx, Diabetes, Breast cancer, Prostate cancer, Heart disease, Depression, High cholesterol, Osteoporosis, Vaccines, Autism, ADHD, Infertility, Weight loss, Cancer, Alzheimer's, Trans fats, Acrylamides, Fluoride, Mercury	Take Action: Support NaturalNews.com Email this article to a friend Share this article on: NewsVine | digg | del.icio.us Permalink to this article: http://www.NaturalNews.com/012924_Merck_heart_attack_Vioxx.html Reprinting this article: Non-commercial use OK, cite NaturalNews.com with clickable link. <a href = "http://www.NaturalNews.com/012924_Merck_heart_attack_Vioxx.html">Attorney accuses Merck of concealing information about Vioxx's dangers</a>
Receive our Natural Health Newsletter for FREE Subscribe now (it's free!) to win. We randomly choose a subscriber each month to send $100 in eco-home products or a RealGoods.com gift certificate (our choice). Plus, you'll receive FREE news, articles and action alerts from NaturalNews.com editors and join over 800,000 monthly readers who report extraordinary health improvements after becoming a subscriber! Receive breaking news alerts on natural health solutions, renewable energy, the environment, global warming and more. Receive a free instant download of our $29 Secret Sources guide that reveals top sources for little-known health and diet solutions.	Your Email Address: Free Subscription Code: Enter the numbers you see: 100% free of charge. Unsubscribe anytime. Absolutely no spam. We respect your email privacy.
Recommended Special Report: Seven Words that can Change the World by Joseph R. Simonetta Read this special report now... "Seven Words That Can Change the World reveals the astonishing, simple truths that have the power to forever transform our world for the better while freeing our minds from the enslavement of limiting beliefs. This is not a text for the simple-minded; it is a guiding philosophy for the mindful, intelligent few who are wise enough to seek out -- and recognize -- the higher simplicities of truly purposeful living." - Mike Adams, the Health Ranger, editor of NaturalNews.com	More on NaturalNews.com: • Streaming Health Ranger Videos • CounterThink Cartoons • FREE Special Reports • Podcasts